Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion type Assertion NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_head.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion description "[This indicates that persistent expression of the MET oncogene is mandatory until the advanced phases of cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_provenance.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion evidence source_evidence_literature NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_provenance.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion SIO_000772 17684486 NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_provenance.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion wasDerivedFrom befree-20140225 NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_provenance.
- NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_assertion wasGeneratedBy ECO_0000203 NP787044.RAyR2iZt0AoeMeiUnvjakqTqgVK0rC5jAOugk50sleHLM130_provenance.